Business
SNG: Ibnsina Pharma leads Egypt’s pharmaceutical distribution market with 31.1% share in H1 2025
SNG: Ibnsina Pharma leads Egypt’s pharmaceutical distribution market with 31.1% share in H1 2025
About this update from Ibnsina Pharma
Staff WriterArab Finance: Ibnsina Pharma has retained its leading position among pharmaceutical distributors in Egypt, with a 31.1% market share in the first half (H1) of 2025, according to IQVIA reports.The company has steadily strengthened its dominance, growing from a 24.2% share in 2023 to 30.8% in 2024.IQVIA data also showed Ibnsina Pharma ranked first in the pharmacy and wholesale sector, holding a 35% share of a segment that accounts for 69% of the overall drug market.The company further maintained its lead as the largest private distributor to public and private hospitals, capturing 22.3% of a sector representing around 31% of the market.IQVIA reported that Egypt’s pharmaceutical market reached sales of EGP 186.7 billion in H1 2025, up from EGP 119.6 billion a year earlier, marking a 56% growth rate following drug price adjustments linked to the 2024 currency devaluation.Ibnsina Pharma recorded revenue growth of 54.8% in H1 of 2025, with revenues reaching EGP 35 billion compared to EGP 22.8 billion in the same period of 2024.© 2025 All Rights Reserved Arab Finance For Information Technology Provided by SyndiGate Media Inc. (Syndigate.info).Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.